Atalanta Therapeutics
Developer of targeted RNA-modulating therapeutics designed for the treatment of genetically defined diseases. The company utilizes proprietary structure-switching molecules to modulate gene expression...
Valuation
$0
Share Price
N/A
Total Raised
$227M
Last Round
N/A